Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan J Zasowski

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|July 20, 2018
The Importance of Individualized Vancomycin Dosing to Ensure Optimal Exposure Early in TherapyEvan J Zasowski, Thomas P Lodise
Pharmacotherapy|August 21, 2015
The β-Lactams Strike Back: Ceftazidime-AvibactamEvan J Zasowski, Jeffrey M Rybak, Michael J Rybak
American Journal of Infection Control|September 22, 2015
Comparison of outcomes between patients with single versus multiple positive blood cultures for Enterococcus: Infection versus illusion?Kimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2013
Reevaluation of ceftazidime dosing recommendations in patients on continuous ambulatory peritoneal dialysisKatie E Cardone, Darren W Grabe, Evan J Zasowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2016
Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream InfectionsEvan J Zasowski, Kimberly C Claeys, Abdalhamid M Lagnf, et al.
American Journal of Infection Control|April 16, 2016
Comparison of clinical outcomes and risk factors in polymicrobial versus monomicrobial enterococcal bloodstream infectionsAbdalhamid M Lagnf, Evan J Zasowski, Kimberly C Claeys, et al.
Infectious Diseases and Therapy|March 26, 2026
Impact of Risk Factor Combinations on Severe COVID-19 Outcomes Among OutpatientsHaley J Appaneal, Vrishali V Lopes, Laura Puzniak, et al.
The Journal of Antimicrobial Chemotherapy|June 19, 2016
Characterization of the haematological profile of 21 days of tedizolid in healthy subjectsThomas P Lodise, Monique R Bidell, Shawn D Flanagan, et al.
International Journal of Antimicrobial Agents|July 3, 2017
Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infectionsKimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|November 23, 2017
Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional AnalysisKimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|July 20, 2018
The Importance of Individualized Vancomycin Dosing to Ensure Optimal Exposure Early in TherapyEvan J Zasowski, Thomas P Lodise
Pharmacotherapy|August 21, 2015
The β-Lactams Strike Back: Ceftazidime-AvibactamEvan J Zasowski, Jeffrey M Rybak, Michael J Rybak
American Journal of Infection Control|September 22, 2015
Comparison of outcomes between patients with single versus multiple positive blood cultures for Enterococcus: Infection versus illusion?Kimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2013
Reevaluation of ceftazidime dosing recommendations in patients on continuous ambulatory peritoneal dialysisKatie E Cardone, Darren W Grabe, Evan J Zasowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2016
Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream InfectionsEvan J Zasowski, Kimberly C Claeys, Abdalhamid M Lagnf, et al.
American Journal of Infection Control|April 16, 2016
Comparison of clinical outcomes and risk factors in polymicrobial versus monomicrobial enterococcal bloodstream infectionsAbdalhamid M Lagnf, Evan J Zasowski, Kimberly C Claeys, et al.
Infectious Diseases and Therapy|March 26, 2026
Impact of Risk Factor Combinations on Severe COVID-19 Outcomes Among OutpatientsHaley J Appaneal, Vrishali V Lopes, Laura Puzniak, et al.
The Journal of Antimicrobial Chemotherapy|June 19, 2016
Characterization of the haematological profile of 21 days of tedizolid in healthy subjectsThomas P Lodise, Monique R Bidell, Shawn D Flanagan, et al.
International Journal of Antimicrobial Agents|July 3, 2017
Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infectionsKimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|November 23, 2017
Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional AnalysisKimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
Pageof 5